4//SEC Filing
Truitt Kenneth 4
Accession 0001214659-22-010993
CIK 0001398733other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:30 PM ET
Size
8.7 KB
Accession
0001214659-22-010993
Insider Transaction Report
Form 4
Truitt Kenneth
Chief Medical Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-09-06+100,000→ 100,000 totalExercise: $1.25Exp: 2032-09-06→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Granted as an inducement equity award under the Aquestive Therapeutics, Inc. 2022 Inducement Equity Incentive Plan in accordance with Nasdaq Listing Rule 5636(c)(4). The options will vest annually 25% on the first and second anniversaries of the Grant Date and 50% on the third anniversary of the Grant Date, subject to Dr. Truitt's continued employment through the applicable vesting date.
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001946056
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 4:30 PM ET
- Size
- 8.7 KB